Search

The article focuses on the classes of drugs and delivery systems which changed the way of how glaucoma is being treated in U.S. Topics discussed include statement from medical doctor (MD) Michael Stiles regarding compliance which is the biggest issue in medical therapy, several drugs used in glaucoma treatment, including zioptan, simbrinza, and rescula, and mechanisms of rho-kinase inhibitors in intraocular pressure (IOP) reduction.

The article focuses selection of compounding pharmacies. Topics discussed include a study performed by researcher Roger A. Goldberg which led to development of Streptococcus endophthalmitis by injecting intravitreal bevacizumab, the Drug Quality and Security Act (DQSA) signed by U.S. President Barack Obama on November 27, 2013. Also mentions that sections of DQSA require the U.S. Food and Drug Administration (FDA) to create list of medicines that should not be compounded.

The article discusses the combination of LASIK with cross-linking, for ensuring corneal stability and avoiding corneal ectasia. Topics discussed include views of Doctor of Medicine (MD) Peter Hersh regarding benefits of cross-linking in strengthening the cornea, refractive stabilizing nature of LASIK Xtra in treatment of myopia, and safety benefits of dubbed LASIK Xtra.

The article focuses on the use of refractive surgery for the treatment of cataract. The preoperative and postoperative superficial keratectomy patient topography is demonstrated. Suggestions are also offered on the implant of contact lenses, correction of a refractive error and on the stability of refraction.

The article focuses on the treatment of dry eye. It states that Sheldon Herzig, medical director and co-founder of the Herzig Eye Institute in Toronto, Ontario, has reported about the qualification of patients with meibomian gland dysfunction and dry eye for laser correction. It mentions about the incorporation of a dry-eye center of excellence in the practice of ophthalmologist Marguerite McDonald. It discusses the LipiView, the LipiFlow and the intense pulsed light (IPL) therapy for dry eye.

The article offers information on how to deal with cataract patients of different age old groups. It suggests to that doctor should try to know the background of patient before going through surgery. Robert M. Kershner, professor at the Palm Beach State College, Florida states that doctor should patiently listen to every patient and should focus on the needs of the patients.

The article offers information on new topical glaucoma medications and delivery systems. According to physician Michael Stiles, private practice in Overland Park, Kansas, majority of patients require more than one medication. Information on a study conducted at the Canada-based University of Toronto found that low-income patients are less likely to be compliant while using eye drops.

The article presents information on the problem of physician burnout that has been one of the main issues of the health care industry of the U.S. It informs that in a survey that compared the burnout and satisfaction with work, it has been found that 45.8 percent of physicians reported at least one symptom of burnout. It further informs that there is much less division between work life and home life.

The article offers information on the management of zonular weakness during cataract surgery. It states that zonular weakness occurs due to pseudoexfoliation so the U.S. surgeons should determine the dilation of pupil and then compare the anterior chamber depth of the eye to its axial length. It further states that surgeons are using capsular tension rings and capsule hooks for managing zonular weakness.

The article offers information on the availability of over the counter artificial (OTC) tear drops for dry eye patients. It informs that patients with severe dry eye are recommended to use preservatives free eye drops which include the Refresh from Allergan Inc., the Soothe from Bausch + Lomb and the Systane from Alcon. As per John Sheppard, a professor of ophthalmology at Eastern Virginia Medical School, lipid can be used to mimic the biphasic nature and an aqueous component to the tear.

The article offers information on Demodex mite infestation as one of the causes of blepharitis. It says that itching, burning, and foreign body sensation are the main symptoms of Demodex mite infestation. It mentions that lid scrub with tea tree oil can be used to eliminate mites as well as total body cleaning.

The article discusses the expected retina epidemic with the increased use of anti-vascular endothelial growth factor (VEGF), obesity, and aging. It mentions the increase of patient visits into office after using anti-VEGF due to other diseases like proliferative diabetic retinopathy. It adds that retina specialists will need to have more efficient approach and spaces to cover their increasing patients. Retina specialist doctor John Thompson suggests to streamline operations and use technicians.

The article focuses on the investigations on corneal inlays, sclera implants and laser procedure as the options for presbyopia correction. It says that a study is conducted to know the safety and efficacy of Kamra corneal inlays, PresbyLens and Flexivue Microlens. It states that doctor Michael Gordon notes that PresVIEW sclera implant shows promise of better surgery. It adds that a study conducted in Spain revealed that monovision correction by LASIK improved near vision in presbyopia patient.

The article reports on the ways to increase revenue and patient flow rate in ophthalmology clinics in the U.S. It focuses on three strategies which can increase the number of patients visiting a particular practitioner which include enhancing customer experience, using Brevium Software to track patient's medical history and adding new services like cosmetic surgery. It also mentions premium services provided by Center for Sight, an eye care centre.

The article discusses how to address the connectivity problem in the electronic health record (EHR) system. It mentions the importance of ensuring that the existing equipment in the office can be connected easily before using an EHR system. Meanwhile, it suggests that technology is expected to continue improving as the EHRs are implemented in additional practices.

The article discusses the symptoms, prevention, and treatment of ocular allergy. It states that seasonal and perennial allergic conjunctivitis are the most common forms of ocular allergy with similar symptoms such as bilateral ocular itch, hyperemia, lid edema, photophobia, chemosis, and tearing. It cites various agents to prevent allergen from penetrating ocular surface such as antihistamines, mast-cell stabilizers, topical nonsteroidal anti-inflammatory drugs (NSAID) and steroids.

The article focuses on LASIK flaps created by femtosecond lasers and the advantages it offers in refractive surgery. It mentions that specifics of various cuts of femtosecond flaps are still being studied such as the side cut angle, flap size, and the thickness of the flap. Uday Devgan, surgeon in Los Angeles, California says that postop cataract patient can use LASIK for vision enhancement. Steven Schallhorn, a surgeon adds that surgeons are trying to determine the perfect flap thickness.

The article offers information on various dry-eye treatments under Phase II and III trials of the U.S. Food and Drug Administration (FDA). It states that the CF101 A3 adenosine receptor agonist from Can-Fite BioPharma Ltd. will be subjected to Phase III clinical trial to compare the efficiency of two doses with placebo. It says that sodium hyaluronate was shown to be efficient for dry eye treatment. Meanwhile, a Phase III trial for diquafosol will confirm the drug's safeness and efficiency.

The article offers information on the policy paper of the Infectious Disease Society of America as part of its Special Area of Focus titled "Bad Bugs, No Drugs 10 New Antibiotics by 2020." According to doctor of pharmacy Joseph Bertino, they are concerned about the bacteria methicillin-resistant Staphylococcus aureus (MRSA), Staphylococcus epidermis and Acinetobacter. Doctor Francis Mah said that the newer antibiotics are re-worked variations of old antibiotics and will be a short-term solution.

The article focuses on the efficacy of bevacizumab (Avastin) and ranibizumab (Lucentis) for the treatment of corneal neovascularization. According to associate professor at Rocky Mountain Lions Eye Institute Richard Davidson, anti-vascular endothelial growth factor (anti-VEGF) can be used in treating inflammatory conditions that cause neurovascularization of the cornea. Moreover, it notes that dexamethasone plus bevacizumab groups reduces the area of corneal neovascularization.

The article discusses various technologies that effectively measure intraoccular pressure (IOP). It states that Goldmann applanation tonometry remained the gold standard for measuring IOP, however, it also has several flaws that affect accuracy in determining the disease. It mentions the effectiveness of pneumotonometry, Tono-Pen, rebound tonometry, as well as the Pascal Dynamic Contour Tonometer, which are increasingly adopted in the field of ophthalmology due to their accuracy.

The article focuses on the use of electronic health records (EHR) by ophthalmologists in the U.S. It notes that the Centers for Medicare & Medicaid Services (CMS) are giving incentives unitl 2015 to physicians to help cut cost for using the EHR system. It says that after 2015 the CMS will penalize physicians who do not comply the requirements for the meaningful use of the technology.

The article focuses on various factors and strategies to consider when planning to sell an ophthalmology practice. According to the author, one priorities in planning is to maximize the profit of a practice. Amy Galloway, director at Tripp Scott PA, says that one way of optimizing a practice's profit is through having better reimbursement rates. The author adds another factor to consider is to improve a practice's curb appeal.

The article offers information on the latest generation of multifocal and accommodating intraocular lenses which are easier to implant and offer better visual results than previous generations. It presents the views of several surgeons on the performance of the newer generation products. It also mentions the names of several products such as Alcon Acrysof's ReSTOR +4.0, Abbott Medical Optic's Tecnis multifocal lens, and Bausch & Lomb Inc.'s Crystalens.

The article reports that patients with sustained trauma to the eye and patients with congenital aniridia can undergo iris implants after receiving a compassionate use exemption from their doctor. It mentions that there are only three companies in the U.S. manufactures iris implants although it did not receive approval from the Food and Drug Administration. It notes that the CustomFlex Artificial Iris manufactures realistic iris implants which can be implanted through a small incision.

The article reports on the diagnosis and the management of ischemic optic neuropathy (ION). It reveals that patients with both anterior and posterior ischemic optic neuropathy, which are the two types of ION, present with acute vision loss in one or both eyes that is not associated with pain. It also notes that ION is a major cause of blindness or significantly impaired vision and there are few definitive answers regarding its cause, clinical features and treatment.

The article discusses refractive surgery on children with eye refractive errors. It notes that laser refractive surgery are only being done to people age 18 years and older but there are also instances that such surgery might be suitable to children especially those who suffer with refractive errors and those who cannot wear contact lenses and glasses. It also states that surgeons who operate refractive surgeries prefer laser ablation than LASIK because they do not want to cut the cornea.

The article discusses the advancements in vein occlusion therapy. Topics discussed include the use of anti-vascular endothelial growth factor (anti-VEGF) agents as the standard of treatment and the determination of the efficacy of anti-VEGF injection. The safety and effectiveness of corticosteroids and the combination approach that involves the use of anti-VEGF agents and corticosteroids are then mentioned.

The article focuses on the use of Photrexa Viscous and Photrexa for treating keratoconus and cross linkage of corneal collagen for treatment of keratoconus approved by the U.S. Food and Drug Administration (FDA). Topics discussed include addition of corneal topography in irregular corneas, soaking of cornea with riboflavin drops after removal of epithelium and use of anesthesia that depends upon tolerance level of patients.

The article discusses the efficacy of flouroquinolones Besivance for eye defect treatment. It states that the use of Besivance was approved by the U.S. Food and Drugs Administration (FDA) for the treatment of bacterial conjunctivitis. On the other hand, it mentions that Besivance has distinct differences from other flouroquinolones in the market, while the ophthalmologists have accordingly did not consider it as the fifth generation of flouroquinolones.

The article discusses the scope of trabeculectomy in the treatment of glaucoma. Trabeculectomy has been shown to successfully lower intraocular pressure (IOP), however, it also has shortcomings. Physician Ike K. Ahmed says that severe complications that can occur early and late postoperatively are the biggest issues with trabeculectomy.

The article reports on the findings of the study conducted by the Schepen's Eye Research Institute regarding ophthalmology in Boston, Massachusetts. It was found that pre-operative tear volume may affect recovery of the ocular surface after laser in situ keratomileusis (LASIK). It was determined that optimization of the ocular surface using artificial tears or nutrition supplements in patients with preoperative dry-eye symptoms decreases the incidence of more severe symptoms preoperatively.

The article focuses on developments in the use of central corneal thickness (CCT) in the assessment of potential glaucoma patients. It discusses the role of intraocular pressure (IOP) in the diagnosis of glaucoma and cites a study published by the American Academy of Ophthalmology, which indicated that CCT plays a significant role in ocular examination. Moreover, it highlights the study conducted by German researchers on the relationship between thinner mean CCT and visual field loss.

The article offers tips that will help ophthalmologists deal with complaints of patients with visual problems after they undergone intraocular (IOL) implantation. It is best to empathize with patients, assure them that their condition will improve, which it often does, and advise them to use a silicone lens with lower refractive index. The vision of patients can improve through the correction of residual refractive errors and alignment of the central optic of the IOL with the pupil.

The article offers tips on how to attract the Generation Y patients of laser-assisted in situ keratomileusis (LASIK) in the U.S. It cites that surgeons would operate on patients who are older than 25 to make sure that their refractive errors are stable. Moreover, it is noted that contact lens wear and care would be more easier, comfortable and affordable than before. It also suggests the use of Internet advertising and the discussion of the LASIK procedure among these age group.

The article discusses the efficiency of routine cataract surgery in treating cystoid macular edema (CME). CME is the most common cause of visual decline after uncomplicated cataract surgery and can have long-term consequences for patients. The incidence of CME after routine cataract surgery has not changed, but surgeons are gaining a better understanding of its impact on patients and how to prevent its occurrence.

The article reports on cataract procedures which are innovative and creative ways to minimize preoperative chair time. The 2005 ruling of the Centers for Medicare and Medicaid Services permits Medicare beneficiaries the option of upgrading to presbyopia-correcting IOLs has made the majority of cataract patients refractive surgery candidates.

The article reports on the development of the dual-optic, deformable and injectable intraocular lenses (IOL) by various opthalmological companies in the U.S. By accommodating IOL, it offers several advantages over other types of IOL, and physician David Chang said that despite improvements in their design, the latest generation of multifocal IOL still has significant trade-offs.

Reports on the approval given by Food and Drug Administration to Allergan Pharmaceuticals company's cyclosporine Restasis, as an agent to treat dry eye syndromes and several off-label applications in the U.S. Statement cited by medical doctor and study author Stephen C. Pflugfelder, about the supplement and safety record of commercially available cyclosporine; Percentage of patients who were given Restasis had a triple increase on the quality of their tears; Application of the drug to prevent and treat post-LASIK dry eye syndrome.

The article discusses how the medical profession and electronic health record (EHR) vendors can safeguard their patient records. Medical organizations and EHR vendors must secure their records because it is a shared responsibility and they can be sued if patient information is compromised. It is explained that providers must be aware of those accessing patient information, what they are doing with the information and ensure that those unauthorized do not gain access.

The article focuses on stress to physicians related to health care reform, electronic medical records and high expectations from patients, and discusses how to handle and remain focused under such situations. Topics discussed include effect of stress on all areas of a physician's life including work-life, separation of work life from home life, and self-care and wellness while maintaining an outward focus.

The article discusses toric intraocular lenses (IOLs) used to correct alignment of the lenses inside the eye, and mentions how toric is successful and intraoperative suggestions for eye surgeons. Topics discussed include toric corrects corneal astigmatism axis, corneal topography in right position, and emmetropia. It presents the views of surgeon Uday Devgan on the benefits of using toric lenses.

The article focuses on the benefits of operating in ambulatory surgery centers (ASCs) over hospitals for patients, surgeons and payers as of May 2014. Topics discussed include a study on the efficiency of the ASCs measured in five categories including safety, patient centeredness, and timeliness, the views of Stephen C. Sheppard of Medical Consulting Group, Missouri on the cost-effectiveness of ASCs, and the economic and quality-of-life benefits of the ASCs.

The article discusses the causes and treatment of blepharitis. According to Scheffer C. G. Tseng, medical director of the Ocular Surface Center in Miami, Florida, blepharitis is characterized by inflammation of the eyelids. He mentions that anterior blepharitis is commonly caused by a staphylococcal infection of the lid margin. According to eye specialist Stephen C. Pflugfelder, some topical treatments for blepharitis include topical steroids and topical azithromycin.

The article discusses the use of drugs which block the effects of vascular endothelial growth factors (VEGF) as the best treatment for retinal diseases. It discusses the approaches used by the retinal specialists for treating wet age-related macular degeneration (AMD) using anti-VEGF agents. It discusses several treatments including continuous treatment at fixed intervals and p.r.n. treatment.

The article focuses on the final regulations of the Physician Payment Sunshine Act imposed by the Centers for Medicare & Medicaid Services (CMS) in the U.S. It states that the pharmaceutical and device companies will be required to start recording data on their relationships with physicians on August 1, 2013 and submit their first federal reports on March 31, 2014. Moreover, the companies will be required to report anything of value that they give to doctors on excess of $10.

The article focuses on enVista, a hydrophobic acrylic intraocular lens (ILO) launched by Bausch and Lomb Inc. It is the only lens which has been approved by the U.S. Food and Drug Administration (FDA) and has been labeled as glistening free. Physician Peter Heimer from the Vision Eye Institute of Gold Coast, Australia presented a poster on this ILO at the American Academy of Ophthalmology highlighting the positive impact of ILO.

The article focuses on the effectiveness of Intacs and corneal collagen cross-linking treatment procedures in Keratoconus and ectasia, eye diseases. It also states that treatment with combination of these procedures better results in comparison to each one distinctly. It also mentions that Intacs supports the cornea and make the corneal contour more symmetric which improves the spectacle-corrected vision of the patient.

The article discusses strategies for ophthalmologists on how to choose between in-house and web-hosted storage in their electronic health record (EHR) in the U.S. It advises the need for ophthalmologists to weigh their options, and to consider the size and location of their practice, as well as their financial situation before choosing the right cloud computing option. It also suggests ophthalmologists to choose an option that will be financially practical in their practice.